Studying gut bacteria in people with inflammatory bowel disease
Observes gut bacteria and related features in Korean patients with inflammatory bowel disease.
Plain-language title generated from the registry record
Registry title: Gut Microbiome in Inflammatory Bowel Disease
Key facts
- Where
- Seoul, South KoreaSee the site
Where in South Korea
- Kyung Hee University HospitalSeoul, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Kyunghee University Medical Center
- Trial code
- NCT03589183
- Record updated
- 10 March 2023
- Original description
Inflammatory bowel disease (IBD) is a chronic inflammatory condition for gastrointestinal tract. There have been numerous studies to reveal dysbiosis of fecal/mucosal microbiome composition in IBD patients but actual trend of dysbiosis is strikingly different among patient's ethnicity.Read full original descriptionShow less
Discovery of Gut Microbial Signatures in Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is a chronic inflammatory condition for gastrointestinal tract. There have been numerous studies to reveal dysbiosis of fecal/mucosal microbiome composition in IBD patients but actual trend of dysbiosis is strikingly different among patient's ethnicity.
In this background, the investigators have composed a prospective cohort of Korean IBD patients in a large academic referral IBD center. Using an integrated multi-omics bioinformatic analysis, the investigators aim to explore gut microbial signatures along with distinct clinical/genetic features, and their potential interplay in patients with IBD.
Inclusion: Patients with established diagnosis of inflammatory bowel disease, including ulcerative colitis and Crohn disease.
Exclusion: Person with history of using antibiotics or probiotics within previous 2 weeks.